Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about STAT1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No AI portrait yet
| Gene Symbol | STAT1 |
| Full Name | Signal Transducer and Activator of Transcription 1 |
| Aliases | Page for STAT1 Gene |
| Chromosome | 2q32.2 |
| Protein Type | Transcription Factor |
| Function | is an important component in the neurobiology of neurodegenerative diseases. |
| Molecular Weight | 84 kDa |
| Pathways | cascade: ### Activation Mechanism, JAK-STAT signaling, JAK-STAT pathway |
| UniProt ID | P42224 |
| NCBI Gene ID | 6772 |
| Ensembl ID | ENSG00000115415 |
| GeneCards | STAT1 |
| Human Protein Atlas | STAT1 |
| Associated Diseases | Als, Autoimmune, Depression, Infection, Inflammation |
| Known Drugs/Compounds | berberine, Curcumin, metformin, valproic acid |
| Interactions | ACE, AGING, AKT1, alpha-synuclein, ALZHEIMER, ALZHEIMER'S DISEASE |
| KG Connections | 858 knowledge graph edges |
| Databases | GeneCardsHPASTRING |
Knowledge base pages for this entity
graph TD
STAT1["STAT1"] -->|"Mediates"| INTERFERON_RESPONSE["INTERFERON_RESPONSE"]
STAT1["STAT1"] -->|"Promotes"| ferroptosis["ferroptosis"]
STAT1["STAT1"] -->|"Activates"| Cardiovascular["Cardiovascular"]
STAT1["STAT1"] -->|"Activates"| Als["Als"]
STAT1["STAT1"] -->|"Activates"| Hypertension["Hypertension"]
STAT1["STAT1"] -->|"Activates"| Obesity["Obesity"]
STAT1["STAT1"] -->|"Activates"| Ms["Ms"]
STAT1["STAT1"] -->|"Activates"| Diabetes["Diabetes"]
JAK2["JAK2"] -->|"Activates"| STAT1["STAT1"]
JAK1["JAK1"] -->|"Activates"| STAT1["STAT1"]
CSF2["CSF2"] -->|"Regulates"| STAT1["STAT1"]
NAMPT["NAMPT"] -->|"Regulates"| STAT1["STAT1"]
FGF2["FGF2"] -->|"Regulates"| STAT1["STAT1"]
style STAT1 fill:#8d4900,color:#e0e0e0
style INTERFERON_RESPONSE fill:#9C27B0,color:#e0e0e0
style ferroptosis fill:#1b5e20,color:#e0e0e0
style Cardiovascular fill:#b71c1c,color:#e0e0e0
style Als fill:#b71c1c,color:#e0e0e0
style Hypertension fill:#b71c1c,color:#e0e0e0
style Obesity fill:#b71c1c,color:#e0e0e0
style Ms fill:#b71c1c,color:#e0e0e0
style Diabetes fill:#b71c1c,color:#e0e0e0
style JAK2 fill:#0d47a1,color:#e0e0e0
style JAK1 fill:#0d47a1,color:#e0e0e0
style CSF2 fill:#8d4900,color:#e0e0e0
style NAMPT fill:#8d4900,color:#e0e0e0
style FGF2 fill:#8d4900,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| STAT1 | encodes | protein | 0.00 |
| Inflammation | activates | disease | 0.95 |
| Interferon Response | involved_in | process | 0.90 |
| ULK1 | associated_with | gene | 0.90 |
| Type I Interferon-Like Gene Signature | mediates | phenotype | 0.90 |
| Interferon-Stimulated Gene Response | involved_in | process | 0.90 |
| SARS-CoV-2 Infection | involved_in | disease | 0.90 |
| Interferon Response | component_of | pathway | 0.90 |
| Interferon-Stimulated Genes | component_of | pathway | 0.85 |
| Sepsis | activates | disease | 0.85 |
| Parkinson's disease | risk_factor_for | disease | 0.85 |
| ULK1 | downregulates | protein | 0.85 |
| Microglial Autophagy | regulates | process | 0.85 |
| Als | inhibits | disease | 0.85 |
| Cancer | activates | disease | 0.85 |
| Lysine Acetylation | involved_in | mechanism | 0.82 |
| neural stem cells | inhibits | cell_type | 0.80 |
| neural stem cells | activates | cell_type | 0.80 |
| Nf-Κb | activates | pathway | 0.80 |
| CANCER | activates | gene | 0.80 |
| JAK1 | activates | gene | 0.80 |
| INFLAMMATION | activates | gene | 0.80 |
| Inflammation | inhibits | disease | 0.75 |
| Als | therapeutic_target | disease | 0.75 |
| Als | regulates | disease | 0.75 |
| Als | activates | disease | 0.75 |
| Cancer | inhibits | disease | 0.75 |
| Carcinoma | activates | disease | 0.75 |
| Tumor | therapeutic_target | disease | 0.75 |
| Inflammation | therapeutic_target | disease | 0.75 |
| Cancer | therapeutic_target | disease | 0.75 |
| Fibrosis | inhibits | disease | 0.75 |
| Tumor | activates | disease | 0.75 |
| INTERFERON_RESPONSE | regulates | pathway | 0.72 |
| ubiquitin-proteasome | participates_in | pathway | 0.70 |
| INFLAMMATION | inhibits | gene | 0.70 |
| CXCL10 | activates | gene | 0.70 |
| IFN | activates | gene | 0.70 |
| JAK-STAT signaling | participates_in | pathway | 0.70 |
| Tgf-Β | activates | pathway | 0.70 |
| MAPK signaling | participates_in | pathway | 0.70 |
| Mtor | activates | pathway | 0.70 |
| apoptosis pathway | participates_in | pathway | 0.70 |
| NF-kB signaling | participates_in | pathway | 0.70 |
| AKT | regulates | gene | 0.70 |
| Jak-Stat | inhibits | pathway | 0.70 |
| Metastasis | activates | pathway | 0.70 |
| TNF-Α | activates | gene | 0.70 |
| CANCER | inhibits | gene | 0.70 |
| PROINFLAMMATORY CYTOKINES | activates | gene | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| STAT1 | encodes | gene | 0.00 |
| Curcumin | inhibits | drug | 0.90 |
| Berberine | upregulates | compound | 0.90 |
| alpha-synuclein | activates | protein | 0.90 |
| TNF | activates | gene | 0.90 |
| JAK1 | phosphorylates | protein | 0.85 |
| SNCA | interacts_with | protein | 0.85 |
| BAX | regulates | gene | 0.80 |
| NF-ΚB | activates | gene | 0.80 |
| CYTOKINES | activates | gene | 0.80 |
| CYTOKINES | inhibits | gene | 0.70 |
| AKT | therapeutic_target | gene | 0.70 |
| ERK | regulates | gene | 0.70 |
| APOPTOSIS | inhibits | gene | 0.70 |
| STAT3 | inhibits | gene | 0.70 |
| METFORMIN | associated_with | drug | 0.70 |
| STAT3 | activates | gene | 0.70 |
| NF-ΚB | inhibits | gene | 0.70 |
| CANCER | associated_with | disease | 0.70 |
| BAX | activates | gene | 0.70 |
| JAK2 | activates | protein | 0.70 |
| IL6 | activates | gene | 0.70 |
| TUMOR MICROENVIRONMENT | regulates | phenotype | 0.65 |
| JAK1 | activates | protein | 0.64 |
| FGF8 | regulates | gene | 0.60 |
| IRF1 | activates | gene | 0.60 |
| HSPA1A | regulates | gene | 0.60 |
| P62 | activates | gene | 0.60 |
| DDX58 | activates | gene | 0.60 |
| CASP8 | regulates | gene | 0.60 |
| NAMPT | regulates | gene | 0.60 |
| ATG3 | regulates | gene | 0.60 |
| JAK1 | inhibits | gene | 0.60 |
| HIF1A | activates | gene | 0.60 |
| CXCL10 | activates | gene | 0.60 |
| S100A8 | regulates | gene | 0.60 |
| CSF2RA | regulates | gene | 0.60 |
| CD4 | therapeutic_target | gene | 0.60 |
| JAK2 | therapeutic_target | gene | 0.60 |
| PTGS2 | therapeutic_target | gene | 0.60 |
| TNF | therapeutic_target | gene | 0.60 |
| MDM2 | therapeutic_target | gene | 0.60 |
| CD44 | inhibits | gene | 0.60 |
| TLR4 | inhibits | gene | 0.60 |
| NRAS | activates | gene | 0.60 |
| MTOR | activates | gene | 0.60 |
| ISG15 | activates | gene | 0.60 |
| RELA | regulates | gene | 0.60 |
| BCL2L1 | regulates | gene | 0.60 |
| JUN | regulates | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TYRO3-STAT1 Axis to Preserve Parvalbumin Interneuron Functio | 0.506 | neuroinflammation | Why do TAM receptors protect against neu |
Scientific analyses that reference this entity
neuroinflammation | 2026-04-14 | 2 hypotheses Top: 0.513
neurodegeneration | 2026-04-07 | 7 hypotheses Top: 0.720
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
closed · Rounds: 4 · Score: 0.73 · 2026-04-21
closed · Rounds: 4 · Score: 0.75 · 2026-04-15
Hypotheses and analyses mentioning STAT1 in their description or question text
No additional research found